John M. Hill

Multicenter Clinical Trial of Bortezomib in Relapsed/Refractory Waldenstrom's Macroglobulinemia: Results of WMCTG Trial 03-248

Steven P. Treon, Zachary R. Hunter, Jeffrey Matous et al. · Clinical Cancer Research · 2007 · 189 citations

Medicine, Hematology, Oncology +13

A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C

Eric Lawitz, Daniel Gruener, John M. Hill et al. · Journal of Hepatology · 2012 · 158 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Thalidomide and rituximab in Waldenstrom macroglobulinemia

Steven P. Treon, Jacob D. Soumerai, Andrew R. Branagan et al. · Blood · 2008 · 143 citations · Full text

Medicine, Hematology, Pharmacotherapy +6

Nutritional composition of okra seed meal

P. A. Savello, Franklin W. Martin, John M. Hill · Journal of Agricultural and Food Chemistry · 1980 · 97 citations

Agriculture, Food Science, Nutritional Sciences +13

GS‐9857 in patients with chronic hepatitis C virus genotype 1–4 infection: a randomized, double‐blind, dose‐ranging phase 1 study

M. Rodríguez‐Torres, S. Glass, John M. Hill et al. · Journal of Viral Hepatitis · 2016 · 65 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17